Skip to main content

2023 ACCP Annual Meeting Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Title

Browse by Poster Title

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#

A
147
A Clinical Quantitative Systems Pharmacology Framework Describing Loncastuximab Tesirine Distribution & to Explore Patient Outcomes from the Lotis-2 Clinical Trial in Patients With B-Cell Lymphomas

Favorite
114
A Clinical Study to Evaluate the Feasibility of Decentralized Clinical Trial Elements in Korean Patients

Favorite
107
A Combined Ex Vivo & Physiologically-based Pharmacokinetic Approach to Determine Fentanyl Dosing in Children on Continuous Renal Replacement Therapy

Favorite
009
A Combined Ex Vivo & Physiologically-based Pharmacokinetic Approach to Determine Fentanyl Dosing in Children on Continuous Renal Replacement Therapy

Favorite
109
A Comparison of Capillary Microsampling Devices Vs Venipuncture in a Single-Dose Clinical Pharmacokinetics Study of Large & Small Molecules

Favorite
144
A Concentration-QT Analysis Identifies No Meaningful Effect of Nirogacestat or Itraconazole on QTcF Interval

Favorite
143
A Meta-Analysis to Understand the Correlation Between Weight Loss & Resolution of Nonalcoholic Steatohepatitis

Favorite
116
A Multi-layer AI Algorithm that Transcribes SDTM Data into Full-length CSR

Favorite
018
A Novel Auto-Injector Design to Maintain Investigator Blinding in Randomised Controlled Trials

Favorite
199
A PBPK-Driven Modeling Approach for Extrapolation of Clinical Pharmacokinetic Results for Oral Nicotine-Containing Products

Favorite
060
A Phase 1 Study of 5-HT2C Superagonist LP352 Shows Robust Brain Penetration, a Strong Correlation Between Plasma & CSF Pharmacokinetics & QEEG Changes Reflecting Receptor Engagement

Favorite
028
A Phase 1, Open-Label, 4-Part, Drug-Drug Interaction Study With Omaveloxolone in Healthy Subjects

Favorite
187
A Phase 1, Open-label, Single Ascending Dose Study to Evaluate the Pharmacokinetics of Vorasidenib in Healthy Japanese & Non-Asian Participants

Favorite
073
A Phase 1, Randomized, Placebo-Controlled, Double-Blind, 2-Period, Fixed-Sequence Study to Assess the Relative Bioavailability & Safety of Low-Sodium Oxybate Between Japanese & Non-Asian Participants

Favorite
064
A Phase 1b, Randomized, Open-Label Study to Evaluate the Pharmacokinetics, Pharmacodynamics & Safety of Vadadustat in Hemodialysis Patients With Anemia Associated With Chronic Kidney Disease

Favorite
070
A Phase I Study of the Absorption, Metabolism & Excretion Following a Single Oral Dose of [14C]-Adagrasib in Healthy Male Subjects

Favorite
174
A Population Pharmacokinetic Analysis to Evaluate the Effect of Race (Japanese vs Non-Asian) on Exposure of Low-Sodium Oxybate

Favorite
079
A Review of Immunogenicity & Its Effect on Efficacy & Safety of Biologics as Reported on the Prescribing Label to Support Strategic Thinking & Planning Labeling Communications

Favorite
020
A Science-based Approach for Recommendation of Antagonist Blockade in the Bioequivalence Studies of Opioid Drug Products

Favorite
112
A Systemic Examination of Natural Language Processing Algorithms in Longitudinal Pharmacokinetic/Pharmacodynamic Analyses

Favorite
170
A Target-mediated Drug Disposition Model to Explain the Nonlinear Pharmacokinetics of the 11-Beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitor BI-187004 in Healthy Subjects

Favorite
138
A Thorough QT Study Using C-QTc to Evaluate the Effects of Centanafadine on Cardiac Repolarization

Favorite
067
Absolute Oral Bioavailability of Milvexian Spray-dried Dispersion Formulation Under Fasted & Fed Conditions in Healthy Adult Participants Using an Intravenous Microtracer Approach

Favorite
035
Adoption of Patient Reported Outcomes in Early Clinical Trials for Oncology Drugs: Challenges & Opportunities

Favorite
145
An Evaluation of POPPK & PBPK Model-based Virtual Controls to Replace Healthy Subject Controls in Organ Impairment PK Studies

Favorite
040
An Interactive Approach for Evaluation of Monoclonal Antibody Dosing in Light of Rapidly Evolving SARS-CoV-2 Variants

Favorite
068
Anakinra Removal by Continuous Renal Replacement Therapy: An Ex-vivo Analysis

Favorite
011
Analysis of Supervised Machine Learning Algorithms & Computational Validation of the Single Nucleotide Polymorphisms of Antioxidant Enzymes & Oxidative Stress Biomarkers in Preterm Neonates

Favorite
034
Application of Hybrid Pharmacometric/Machine-Learning Approach to Inform Moxifloxacin Therapeutic Drug Monitoring in Children

Favorite
027
Application of Modeling & Simulation to Quantitatively Assess Ulotaront Metabolism & the Effect of a CYP450 Inhibitor in Healthy Subjects

Favorite
045
Applications of Physiologically-based Pharmacokinetic Modeling & Model Based Meta-analysis in Hormonal Contraceptive Breakthrough Bleedings Analysis

Favorite
191
Assessing Pediatric Vancomycin Exposures & the Influences of Body Composition

Favorite
118
Assessment of Anti-Drug Antibody Incidence in Subcutaneously Administered Antibody-Based Therapeutics Approved Between 2010-2022

Favorite
133
Assessment of the Effect of P-gp Inhibition on Pharmacokinetics of the RET Inhibitor, Pralsetinib, in Healthy Subjects

Favorite